Market Movers

China Tower’s Stock Price Dips to 0.99 HKD, Recording a 1.98% Decrease: Time to Buy?

China Tower (788)

0.99 HKD -0.02 (-1.98%) Volume: 308.68M

China Tower’s stock price is currently valued at 0.99 HKD, experiencing a slight dip of -1.98% this trading session with a substantial trading volume of 308.68M, yet showing promising growth with a year-to-date increase of +20.73%.


Latest developments on China Tower

Today, China Tower’s stock price experienced a significant drop following a bearish block trade of 2.3 million shares at $1.0, resulting in a turnover of $2.3 million. This unexpected transaction has caused uncertainty among investors, leading to a sell-off of the company’s shares. The market is closely monitoring the impact of this event on China Tower’s overall performance and future stock price movements.


A look at China Tower Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth4
Resilience2
Momentum5
OVERALL SMART SCORE4.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Tower Corporation Limited, a telecommunication company operating in China, has received high scores in Value, Dividend, Growth, and Momentum according to Smartkarma Smart Scores. With a strong focus on providing telecommunication towers construction, maintenance, and ancillary facilities management services, China Tower is poised for long-term success in the telecommunications industry.

Despite a lower score in Resilience, China Tower’s overall outlook remains positive, as indicated by its high scores in key factors such as Value, Dividend, Growth, and Momentum. With its extensive reach throughout China, China Tower is well-positioned to capitalize on the growing demand for telecommunication services in the country, making it a promising investment opportunity for the future.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars